/ Print /

IN THE PIPELINE

Many happy returns: How to retain optical dispensing patients
Unraveling the mystery behind CPT codes, reviews
FDA approves breakthrough drug for HIV patients with dwindling options
FDA approves breakthrough drug for HIV patients with dwindling optionsA new FDA-approved drug offers new hope for patients with multidrug-resistant HIV-1 infection.
First direct-to-consumer test for breast cancer risk hits market
First direct-to-consumer test for breast cancer risk hits marketFDA approved the first direct-to-consumer test for three specific BRCA1/BRCA2 breast cancer gene mutations.
FDA warns about fraudulent flu products
FDA warns about fraudulent flu productsDuring the worst flu season in years, FDA is warning consumers about fraudulent and counterfeit flu and antiviral products from online pharmacies.
Pharma makers pull MS drug from worldwide marketIn a rare move, pharmaceutical manufacturers voluntarily recalled their drug to treat multiple sclerosis after reports of serious brain inflammation in patients.
SD-OCT may help diagnose primary vitreoretinal lymphomaHyper-reflective subretinal infiltrates visible on spectral domain optical coherence tomography (SD-OCT) could help diagnose primary vitreoretinal lymphoma (PVRL), researchers believe.
Top 3 new cancer drugs
Top 3 new cancer drugsThe first radioactive drug to treat a certain type of cancer is among the top 3 new drug approvals for cancer. Here are the other top cancer drug approvals so far in 2018.
Confessions of an innovatorThe development of many innovations in ophthalmology did not happen in a straightforward manner as shown in these case examples.
Worming their way into the newsTwo headlines broke new ground recently when it comes to horror and adversity. Coincidentally, they both involved worms and left eyes: "Woman pulls wiggling cattle worms from her eyeball, makes medical history" appeared along with "Brain-eating pork worm removed from man's eye."